相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Early Wound Site Seeding in a Patient with Central Nervous System High-Grade Neuroepithelial Tumor with BCOR Alteration
Matthew A. Kirkman et al.
WORLD NEUROSURGERY (2018)
CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue
Yuka Yoshida et al.
BRAIN PATHOLOGY (2018)
Crizotinib resistance overcome by ceritinib in an ALK-positive non-small cell lung cancer patient with brain metastases: A case report
Zhouyu Zhu et al.
MEDICINE (2017)
Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
Aaron Simpson et al.
TARGETED ONCOLOGY (2017)
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Anke E. M. van Erp et al.
TARGETED ONCOLOGY (2017)
Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy
Claudia Paret et al.
ONCOTARGET (2017)
HGNET-BCOR Tumors of the Cerebellum Clinicopathologic and Molecular Characterization of 3 Cases
Romain Appay et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma
Marie Regairaz et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy Overlapping Genetic Features With Clear Cell Sarcoma of Kidney
Yu-Chien Kao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Mass balance, pharmacokinetics, and metabolism of linsitinib in cancer patients
Srinivasu Poondru et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Dominik Sturm et al.
CELL (2016)
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy
Claudia Paret et al.
ONCOTARGET (2016)
Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2)
Anita Kort et al.
PHARMACOLOGICAL RESEARCH (2015)
Hedgehog signaling activates a positive feedback mechanism involving insulin-like growth factors to induce osteoblast differentiation
Yu Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney
Angshumoy Roy et al.
NATURE COMMUNICATIONS (2015)
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation
Leonard Girnita et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Synthesis, Structure-Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials
Thomas H. Marsilje et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Initial Testing of a Monoclonal Antibody (IMC-A12) Against IGF-1R by the Pediatric Preclinical Testing Program
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2010)
Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-I receptor and insulin receptor
Mark J. Mulvihill et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma
S. Honda et al.
BRITISH JOURNAL OF CANCER (2008)
Insulin-like Growth Factor 2 Is Required for Progression to Advanced Medulloblastoma in patched1 Heterozygous Mice
Ryan B. Corcoran et al.
CANCER RESEARCH (2008)
Role of the activation loop tyrosines in regulation of the insulin-like growth factor I receptor-tyrosine kinase
Wanqing Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth
KL Gable et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells
W Hartmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
分享论文
